Angiogenesis inhibitors in cancer therapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current opinion in investigational drugs

• Publication date

  2003-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 12901224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• In Vitro Anticancer Activity of Ethanolic Leaves Extract of Avicennia marina against Different Mammalian Cell Lines

  2024cites this paper
• In Vitro Cytotoxicity of Reproductive Stage Withania somnifera Leaf and Stem on HepG2 Cell Line

  2023cites this paper
• Phytochemistry, allelopathy and anticancer potentiality of Withania somnifera (L.) Dunal (Solanaceae).

  2022cites this paper
• Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates.

  2022cites this paper
• A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy

  2021cites this paper
• Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: Correlating in vitro targeted screening and docking

  2019cites this paper
• Invitro anticancer Activity of Whole Plant Ethanolic Extract of Evolvulus alsinoides against Different Cell Lines

  2019cites this paper
• A marine sponge associated fungal metabolite monacolin X suppresses angiogenesis by down regulating VEGFR2 signaling

  2019cites this paper
• Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer

  2018cites this paper
• INVITRO ANTICANCER ACTIVITY OF SPINACIA OLERACEA AGAINST VARIOUS MAMMALIAN CELL LINES

  2017cites this paper
• CYTOTOXICITY SCREENING OF METHANOLIC BULB EXTRACT OF BELLICORYNE PLUMBAGINIFOLIA AGAINST VARIOUS MAMMALIAN CANCER CELL LINES

  2017cites this paper
• Qualitative analysis of tumor growth model under antiangiogenic therapy – choosing the effective operating point and design parameters for controller design

  2016cites this paper
• Controller-managed automated therapy and tumor growth model identification in the case of antiangiogenic therapy for most effective, individualized treatment

  2015cites this paper
• Identification of C38 colon adenocarcinoma growth under bevacizumab therapy and without therapy

  2014cites this paper
• Determination of withaferin a content of root, stem and leaf extracts of withania somnifera (l) dunal collected in Kenya

  2014cites this paper
• Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases

  2013cites this paper
• Phytochemical Screening of a Polyherbal Extract and Its Anticancer Potential

  2012cites this paper
• Expression of endoglin and podoplanin in early and advanced oral squamous cell carcinoma

  2012cites this paper
• In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania Somnifera against Various Human Cancer Cell Lines

  2010cites this paper
• Tumour‐selective antivascular effects of the novel anti‐mitotic compound A‐318315: An in vivo rat regional haemodynamic study

  2010cites this paper
• Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm

  2009cites this paper
• Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.

  2008cites this paper
• A quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors: Derivatives of N-Phenyl-N′-{4-(4-quinolyloxy)phenyl}urea as antitumor agents

  2008cites this paper
• approach to experimental colitis Angiogenesis blockade as a new therapeutic

  2008cites this paper
• Angiogenesis blockade as a new therapeutic approach to experimental colitis

  2006cites this paper
• Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis.

  2006cites this paper
• Effect of thalidomide on colorectal cancer liver metastases in CBA mice

  2005cites this paper
• Pigment epithelium-derived factor as a new diagnostic marker for melanocytic tumors.

  2005cites this paper
• Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis.

  2005cites this paper
• Antiangiogenic Steroids in Human Cancer Therapy

  2005cites this paper
• Inhibition of Xenografted Human Melanoma Growth and Prevention of Metastasis Development by Dual Antiangiogenic/Antitumor Activities of Pigment Epithelium-Derived Factor

  2004cites this paper
• Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study

  2004cites this paper
• Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?

  2004cites this paper
• c-Myc as a therapeutic target in cancer

  2004cites this paper
• A Mathematical Model for the Role of Cell Signal Transduction in the Initiation and Inhibition of Angiogenesis

  2003influential citation
• Mechanism and its regulation of tumor-induced angiogenesis.

  2003cites this paper
• Hemostasis, Thrombosis, and Vascular Biology

  year unknowncites this paper